Terumo Blood and Cell Technologies' IMUGARD Platelet Pooling Set Cleared by FDA streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
IMUGARD to Help Strained U.S. Platelet Supply Meet Growing Need LAKEWOOD, Colo., Feb. 17, 2023 /PRNewswire/ Today, Terumo Blood and Cell Technologies announces U.S. Food and Drug Administration (FDA) clearance and official launch of its IMUGARD® WB Platelet Pooling Set, which supports extended shelf life of whole blood-derived platelets from five days to seven days.[1] IMUGARD is the.
A panel of federal health advisers will likely vote on a recommendation in the spring, potentially ending a controversial policy that's persisted for decades.